[Form 3] Sol-Gel Technologies Ltd. Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

Sol-Gel Technologies Ltd. executive Ofra Levy-Hacham, VP Clinical, Regulatory & Quality, filed an initial Form 3 reporting her beneficial ownership of several stock option grants over the company’s ordinary shares. These options are held directly, with exercise prices ranging from $8.96 to $100.00 per share and expiration dates between August 2026 and February 2035.

According to the filing, some of the options are already fully vested, while others began vesting 25% on specific dates in 2023, 2024, and 2026 and will continue to vest in equal quarterly installments over the following three years, subject to her continued service with the company.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Levy-Hacham Ofra

(Last) (First) (Middle)

C/O SOL-GEL TECHNOLOGIES LTD.

7 GOLDA MEIR STREET

(Street)

NESS-ZIONA 7403650

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Sol-Gel Technologies Ltd. [ SLGL ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP Clinical, Reg & Quality

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	(2)	08/01/2026	Ordinary Shares(1)	569	$15.89	D
Stock Option (right to buy)	(3)	07/13/2027	Ordinary Shares(1)	3,568	$55.66	D
Stock Option (right to buy)	(4)	03/29/2032	Ordinary Shares(1)	6,092	$100	D
Stock Option (right to buy)	(5)	03/09/2033	Ordinary Shares(1)	6,790	$56	D
Stock Option (right to buy)	(6)	02/18/2035	Ordinary Shares(1)	1,000	$8.96	D

Explanation of Responses:

1. Ordinary shares, NIS 1.00 par value per share.

2. The option is fully vested.

3. The option is fully vested.

4. The option vested as to 25% of the Ordinary Shares on March 29, 2023 and vests as to the remainder of the Ordinary Shares in equal quarterly installments over the following three years, subject to the Reporting Person's continued service through such dates.

5. The option vested as to 25% of the Ordinary Shares on March 9, 2024 and vests as to the remainder of the Ordinary Shares in equal quarterly installments over the following three years, subject to the Reporting Person's continued service through such dates.

6. The option vested as to 25% of the Ordinary Shares on February 18, 2026 and vests as to the remainder of the Ordinary Shares in equal quarterly installments over the following three years, subject to the Reporting Person's continued service through such dates.

Remarks:

Exhibit 24 - Power of Attorney

	/s/Eyal Ben-Or, Attorney-in-Fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)